Related Experiment Video
Updated: Jul 3, 2025
06:48
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
21.3K
Exosomal noncoding RNA: A potential therapy for retinal vascular diseases.
Jong-Ik Heo1,2, Juhee Ryu1,2
1Vessel-Organ Interaction Research Center, College of Pharmacy, Kyungpook National University, Daegu, South Korea.
Molecular Therapy. Nucleic Acids
|February 15, 2024
Summary
Exosomes carrying noncoding RNAs show promise for treating retinal vascular diseases. Engineering these exosomes offers new diagnostic biomarkers and therapeutic targets for conditions like diabetic retinopathy and macular degeneration.
Area of Science:
- Ophthalmology and Molecular Biology
- Extracellular Vesicles and RNA Therapeutics
Background:
- Exosomes, secreted vesicles containing biomolecules, facilitate cell-to-cell communication and are explored for retinal vascular disorder therapies.
- Current research investigates exosomes for treating glaucoma, dry eye, retinal ischemia, diabetic retinopathy, and age-related macular degeneration.
- The specific role of exosomal noncoding RNA in retinal vascular diseases requires further elucidation.
Purpose of the Study:
- To review the latest research on the biological role of exosomal noncoding RNA in treating retinal vascular diseases.
- To highlight the potential of exosomal noncoding RNA as biomarkers and therapeutic targets.
Main Methods:
- Literature review of recent studies on exosomal noncoding RNA and retinal vascular diseases.
- Analysis of the regulatory roles of microRNAs, circular RNAs, and long noncoding RNAs within exosomes.
Main Results:
- Noncoding RNAs (microRNAs, circular RNAs, long noncoding RNAs) within exosomes significantly regulate retinal vascular diseases.
- Exosome engineering allows for controlled expression of noncoding RNAs to manage these conditions.
Conclusions:
- Exosomal noncoding RNA is a promising area for developing diagnostic biomarkers for retinal vascular diseases.
- Targeting exosomal noncoding RNA presents a viable therapeutic strategy for various retinal vascular conditions.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K